ONCOLOGY Nurse Edition February 2009, Vol 23 No 2

Publication
Article
Oncology Nurse EditionONCOLOGY Nurse Edition Vol 23 No 2
Volume 23
Issue 2

Recent Videos
Patients with node-negative disease who are older and have comorbidities may not be suitable to receive CDK4/6 inhibitors.
2 experts in this video
An observed carryover effect with CDK4/6 inhibitors may reduce the risk of recurrence years after a patient stops treatment.